期刊文献+

人抗菌肽FALL-39突变分子的特性和抗菌功能的比较 被引量:4

Comparing the protein characteristics and antibacterial activity of antibacterial peptide FALL-39 and its mutant peptides
下载PDF
导出
摘要 目的对人抗菌肽FALL-39不同突变分子蛋白的特性及抗菌功能进行初步的比较。方法应用AU-PAGE电泳、RP-HPLC、Om iga蛋白分析软件,比较FALL-39及其突变蛋白FALL-39-Lys24、FALL-39-Lys32、FALL-39-Lys24′32的特性;测定M IC、MEC和MBC值,并比较抗菌作用。结果突变蛋白AU-PAGE电泳迁移速率较快,RP-HPLC出峰时间未见改变,蛋白的亲疏水性、α螺旋结构、抗原性等蛋白特性无明显改变。M IC、MEC和MBC值表明FALL-39突变肽对大肠杆菌和绿脓杆菌的抗菌活性有所增强。结论突变蛋白在增加正电荷的同时,虽未改变蛋白的特性,但抗菌活性增强。 OBJECTIVE To compare the protein characteristics of antibacterial peptide FALL- 39 and its mutant peptides. METHODS Using AU - PAGE elution, HPLC and omiga analysis software, the protein characteristics of purified peptides of FALL - 39 and its mutant peptides, FALL-39- Lys32, FALL- 39 -Lys24 and FALL- 39 -Lys24'32 were analyzed. MEC, MIC and MBC were used to assay the antibacterial activities of these peptides. The antibacterial assay showed that mutant peptides were more potent in the antibacterial activity against E. coli ATCC 25922, E. coli ML 35p and Pseudomonas aeruginosa ATCC 27853 than that of FALL - 39. RESULTS FALL - 39 mutants peptides ran faster than FALL - 39 in AU- PAGE elution, while the retention time of HPLC. Hydrophobicity, protein flexibility and yon heijne transmembrane helices did not change. CONCLUSION FALL - 39 mutant peptides have increasing antibacterial activity and net positive charge, but with no protein characteristics change.
出处 《华西药学杂志》 CAS CSCD 北大核心 2006年第5期422-424,共3页 West China Journal of Pharmaceutical Sciences
基金 CMB(98-681)基金资助
关键词 人抗菌肽FALL-39 蛋白特性 抗菌功能 突变分子 FALL - 39 Protein characteristics Antibacterial activity Mutant peptide
  • 相关文献

参考文献8

  • 1Lehrer RI, Ganz T. Cathelicidins: a family of endogenous antimicrobial peptides [ J ]. Curr Opin Hemato1,2002 ,9 ( 1 ) : 18 - 22.
  • 2Gudmundsson GH, Agerberth B, Adeberg J, et al. The humangene FALL - 39 and processing of the cathlin precursor to the antimicrobial peptide LL - 37 in granulocytes [ J ]. Eur J biochem,1996, 238(2) : 325 -332.
  • 3Gudmundsson GH, Magnusson KP, Chowdhary BP, et al. Structure of the gene for porcine peptide antibiotic PR -39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL - 39 [ J ]. Proc Natl Acad SciUSA, 1995, 92:7085-7089.
  • 4Yang YX, Feng Yun, Wang BY, et al. PCR - based site - specific mutagensis of FALL -39 and its biologic activities[J]. Acta Pharmacological Sinica, 2004, 25(2) : 239 -245.
  • 5Oren Z, Lerman JC, Gudmundsson GH, et al. Structure and organization of the human antimicrobial peptide LL37 in phospholipid membranes: relevance to the molecular basis for its noncell- selective activity[J]. Biochem J, 1999, 341:501 -513.
  • 6奥斯伯F 布伦特R 金斯顿RE 等 颜子颖 王海林 编译.精编分子生物学实验指南[M].北京:科学出版社,1998.366-373.
  • 7Mark AF, Marek AK. A novel peptide - IgG conjugate, CAP18 106 - 138 - IgG, that binding and neutralizes endotoxin and kills Gram- negative bacteria[J]. Infectious Disease, 1997, 175:621.
  • 8Zhao CQ, Nguyen T, Boo LM, et al. RL - 37, an alpha - helical antimicrobial peptide of the rhesus monkey [ J ]. Antimicrob Agents Chemother, 2001,45 (10) : 2695 -2702.

共引文献154

同被引文献42

  • 1冯新富,黄玉兰,张忠民,石承先,陈晓理,王伯瑶.LL-37抗菌肽重组及其治疗实验性内毒素血症的研究[J].山东医药,2005,45(29):1-3. 被引量:3
  • 2王丽,周源,姜德建,李元建.一氧化氮合酶抑制物在胃黏膜损伤中的作用与机制[J].国际病理科学与临床杂志,2006,26(1):1-6. 被引量:4
  • 3刘阳云,赵素萍.诱导型一氧化氮合酶与环氧合酶-2在肿瘤组织中的共表达[J].国际病理科学与临床杂志,2007,27(1):19-24. 被引量:8
  • 4奥斯伯FM,布伦特R,金斯顿RE,等.精编分子生物学实验指南[M].颜子颖,王海林,译.北京:科学出版社,1999:704.
  • 5Gollob JA, Rathmell WK, Richmond TM, et al. Phase II trial of sorafenib plus interferon alfa-2b as first-or second-line therapy in patients with metastatic renal cell cancer [ J ] . Journal of Clinical Oncology, 2007, 25 ( 22 ) : 3288-3295.
  • 6Marcellin P, Lau GKK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B [ J ] . New England Journal of Medicine, 2004, 351 ( 12 ) : 1206-1217.
  • 7Liu YJ. IPC : professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors [ J ] . Annu Rev Immunol, 2005, 23 : 275-306.
  • 8Vileek J. Novel interferons [ J ] . Nature Immunology, 2003, 4 ( 1 ): 8-9.
  • 9Fensterl V, Sen GC. Interferons and viral infections [ J ] . Biofactors, 2009, 35 ( 1 ) : 14-20.
  • 10De Veer MJ, Holko M, Frevel M, et al. Functional classification of interferon-stimulated genes identified using microarrays [ J ] .Journal of Leukocyte Biology, 2001, 69 ( 6 ) : 912-920.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部